NEPHROS, INC. Deferred Tax Liabilities, Net
NEPHROS, INC. (NEPH) had Deferred Tax Liabilities, Net of $288.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilities · last filed 2022-03-03
- 2021-12-31: Deferred Tax Liabilities, Net $288.00K.
- 2020-12-31: Deferred Tax Liabilities, Net $320.00K.
- 2019-12-31: Deferred Tax Liabilities, Net $134.00K.
- 2018-12-31: Deferred Tax Liabilities, Net $21.00K.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2021-12-31 | $288.00K 10-K · filed 2022-03-03 |
| 2020-12-31 | $320.00K 10-K · filed 2022-03-03 |
| 2019-12-31 | $134.00K 10-K · filed 2021-03-01 |
| 2018-12-31 | $21.00K 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |